FDA Inspection 1028265 — Kolmar Korea Co. Ltd.
The FDA completed an inspection of Kolmar Korea Co. Ltd. on September 28, 2017 in Sejong. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 28, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sejong (Korea (the Republic of))